FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 4.14 $ 0.14 (3.5 %)    

Tuesday, 02-Jul-2024 15:57:58 EDT
QQQ $ 486.52 $ 5.06 (1.05 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 3.67 (0.67 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 4.14
$ 4.22
$ 0.00 x 0
$ 0.00 x 0
$ 4.14 - $ 4.49
$ 3.90 - $ 55.00
328,476
na
128.89M
$ -3.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...